MP78-17 A PHASE II STUDY TO EVALUATE OUTPATIENT, TRANSRECTALLY-DELIVERED, MRI-GUIDED LASER FOCAL THERAPY OF PROSTATE CANCER: 9 YEAR INTERIM RESULTS (NCT 02243033) | Zendy

AI Assistant Blog Pricing

MP78-17 A PHASE II STUDY TO EVALUATE OUTPATIENT, TRANSRECTALLY-DELIVERED, MRI-GUIDED LASER FOCAL THERAPY OF PROSTATE CANCER: 9 YEAR INTERIM RESULTS (NCT 02243033)

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.